UTMD Q4 Operating Income Drops 16.7% to USD 2.4M

Reuters

Jan 29

UTMD Q4 Operating Income Drops 16.7% to USD 2.4M

Utah Medical Products Inc. reported its financial results for the fourth quarter (Q4) and full year (FY) 2025. For Q4 2025, the company reported sales of USD 9.0 million and gross profit of USD 5.3 million, with a gross profit margin of 58.2 percent. Operating income for the period was USD 2.4 million, resulting in an operating income margin of 27.0 percent. Income before tax stood at USD 3.1 million, with a margin of 34.3 percent. Net income margin for the quarter was 28.4 percent. For the full year 2025, Utah Medical Products Inc. reported a gross profit margin of 57.1 percent, an operating income margin of 29.6 percent, income before tax margin of 36.6 percent, and a net income margin of 29.3 percent. The company ended the year with cash balances of USD 85.8 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Utah Medical Products Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1131531) on January 29, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2607038050"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2607038050\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2607038050?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-29 22:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2607038050","market":"fut","top_or_hot":-1,"title":"UTMD Q4 Operating Income Drops 16.7% to USD 2.4M","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      UTMD Q4 Operating Income Drops 16.7% to USD 2.4M\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Utah Medical Products Inc. reported its financial results for the fourth quarter (Q4) and full year (FY) 2025. For Q4 2025, the company reported sales of USD 9.0 million and gross profit of USD 5.3 million, with a gross profit margin of 58.2 percent. Operating income for the period was USD 2.4 million, resulting in an operating income margin of 27.0 percent. Income before tax stood at USD 3.1 million, with a margin of 34.3 percent. Net income margin for the quarter was 28.4 percent. For the full year 2025, Utah Medical Products Inc. reported a gross profit margin of 57.1 percent, an operating income margin of 29.6 percent, income before tax margin of 36.6 percent, and a net income margin of 29.3 percent. The company ended the year with cash balances of USD 85.8 million.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Utah Medical Products Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1131531) on January 29, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>UTMD Q4 Operating Income Drops 16.7% to USD 2.4M</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUTMD Q4 Operating Income Drops 16.7% to USD 2.4M\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-01-29 22:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      UTMD Q4 Operating Income Drops 16.7% to USD 2.4M\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Utah Medical Products Inc. reported its financial results for the fourth quarter (Q4) and full year (FY) 2025. For Q4 2025, the company reported sales of USD 9.0 million and gross profit of USD 5.3 million, with a gross profit margin of 58.2 percent. Operating income for the period was USD 2.4 million, resulting in an operating income margin of 27.0 percent. Income before tax stood at USD 3.1 million, with a margin of 34.3 percent. Net income margin for the quarter was 28.4 percent. For the full year 2025, Utah Medical Products Inc. reported a gross profit margin of 57.1 percent, an operating income margin of 29.6 percent, income before tax margin of 36.6 percent, and a net income margin of 29.3 percent. The company ended the year with cash balances of USD 85.8 million.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Utah Medical Products Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1131531) on January 29, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4198","symbol_name":"医疗保健用品","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260129:nNDLJldGt:1","article_id":"2607038050","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2607038050","pubTimestamp":1769695279,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Utah Medical Products Inc. reported its financial results for the fourth quarter  and full year  2025. For Q4 2025, the company reported sales of USD 9.0 million and gross profit of USD 5.3 million, with a gross profit margin of 58.2 percent. Operating income for the period was USD 2.4 million, resulting in an operating income margin of 27.0 percent. Income before tax stood at USD 3.1 million, with a margin of 34.3 percent. Net income margin for the quarter was 28.4 percent. For the full year 2025, Utah Medical Products Inc. reported a gross profit margin of 57.1 percent, an operating income margin of 29.6 percent, income before tax margin of 36.6 percent, and a net income margin of 29.3 percent. The company ended the year with cash balances of USD 85.8 million.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4198":"医疗保健用品","UTMD":"犹他医疗产品"},"translate_title":"UTMD第四季度营业收入下降16.7%至240万美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"UTMD":0.9},"content_text":"UTMD Q4 Operating Income Drops 16.7% to USD 2.4M\n    \n\n        Utah Medical Products Inc. reported its financial results for the fourth quarter (Q4) and full year (FY) 2025. For Q4 2025, the company reported sales of USD 9.0 million and gross profit of USD 5.3 million, with a gross profit margin of 58.2 percent. Operating income for the period was USD 2.4 million, resulting in an operating income margin of 27.0 percent. Income before tax stood at USD 3.1 million, with a margin of 34.3 percent. Net income margin for the quarter was 28.4 percent. For the full year 2025, Utah Medical Products Inc. reported a gross profit margin of 57.1 percent, an operating income margin of 29.6 percent, income before tax margin of 36.6 percent, and a net income margin of 29.3 percent. The company ended the year with cash balances of USD 85.8 million.\n      \n\n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Utah Medical Products Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1131531) on January 29, 2026, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"express","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}